EcoDrugPlus

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSSFOG00015020782
Gene Symbol: SCN4A
1 Cross references
197 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSSFOG00015003539
Gene Symbol: SCN8A
1 Cross references
272 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSSFOG00015013871
Gene Symbol: SCN8A
1 Cross references
272 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1

Ensembl ID : ENSSFOG00015013739
Gene Symbol: LOC108925556
3 Cross references
276 Possible Orthologues:

Sodium-Dependent Serotonin Transporter-Like

Ensembl ID : ENSSFOG00015005765
Gene Symbol: LOC108932070
3 Cross references
201 Possible Orthologues:

Sodium/glucose Cotransporter 2

Ensembl ID : ENSSFOG00015007244
Gene Symbol: LOC108928760
3 Cross references
198 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSSFOG00015009535
Gene Symbol: LOC108938015
2 Cross references
221 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2-Like

Ensembl ID : ENSSFOG00015031439
Gene Symbol: LOC108920345
3 Cross references
203 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2-Like

Ensembl ID : ENSSFOG00015022521
Gene Symbol: LOC108923116
3 Cross references
204 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-233-Like

Ensembl ID : ENSSFOG00015007427
Gene Symbol: LOC108933198
3 Cross references
294 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3-Like

Ensembl ID : ENSSFOG00015017231
Gene Symbol: LOC108932419
3 Cross references
298 Possible Orthologues:

Solute Carrier Family 18 Member 2

Ensembl ID : ENSSFOG00015018629
Gene Symbol: SLC18A2
1 Cross references
224 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).